Abbott Laboratories

NYSE:ABT   3:59:59 PM EDT
109.03
+1.24 (+1.15%)
Products

Abbott Receives FDA Emergency Use Authorization For COVID-19 IgM Antibody Blood Test

Published: 10/12/2020 13:23 GMT
Abbott Laboratories (ABT) - Abbott Receives FDA Emergency Use Authorization for Its Covid-19 Igm Antibody Blood Test.
Abbott - Data Demonstrates Highly Reliable Test Results With 99.56% Specificity and 95.00% Sensitivity for Patients Tested 15 Days After Symptom Onset.
Abbott Laboratories - Igm Test is Now Available on Abbott's Architect and Alinity Platforms.